Overview
| Name | AIDO Cell · aliases: AIDO Cell 1.0, AIDO.Cell, GB.Cell |
|---|---|
| Full name | The name is a product name; the official page gives no expanded form |
| Ambiguous names (not auto-linked) | AIDO |
| Family | Part of the AIDO family |
| Organization | GenBio AI |
| Organization type | AI-native biotech |
| Country | United States |
| Model class | Virtual cell / multi-scale world model |
| Domain | Single-cell & perturbation (also: Genomics & RNA, Structure & co-folding) |
| First release | Basis: Official launch post with same-day press coverage Note: One outlet gives 08-19 while a same-day report gives 08-18, which is used; the previous generation's single-cell weights appeared in 2024-11 and are a different product source |
| Other milestones | |
| Latest update | · no later event Basis: No sourced substantive event since launch Access is still a waiting list with the early-access programme in preparation and the full white paper available on request; a 2026-07-25 change to the previous generation's repository belongs to a different product line source The most recent sourced event, not a claim that nothing changed since. |
| Status | Product only, no public artifact · No public weights or reproducible materials, waiting list only |
| Openness | Code: Closed Weights: Closed This version releases no weights and its white paper is on request; the previous generation's single-cell weights are on the model hub under the developer's own community licence |
| Benchmarks reported | 0 counted (unconfirmed 1) |
| Wet-lab validation | None recorded |
| Unverified fields | † training_data.a_public, training_data.d_wetlab_validation_only, background.funding |
| As of | 2026-11-16 |
What it does
Simulates DNA, RNA, protein and whole-cell behaviour in one shared state where perturbations accumulate and can be applied in sequence, currently for two prototype cell types only. Unlike transcriptome-perturbation models such as STATE and Lingshu-Cell, its comparators span structure, regulation and splicing models including AlphaFold 3 and AlphaGenome.
Benchmarks reported
Every row is one pairing from the survey's relation file; a score belongs to the benchmark page's ranking, where it is shown with metric, eval set, source type and date. 0 of 1 pairings are counted.
| Benchmark | Relation | Eval set / protocol | Source type | Note and evidence |
|---|---|---|---|---|
| 09 scIB (+Open Problems) | Unconfirmed (not counted) | — | Unconfirmed source | Model card claims zero-shot clustering SOTA; scIB not named, no numbers †disputed · evidence |
Other evaluations (outside the 44)
- Vendor's own virtual-cell evaluation (Public benchmark not among the 44) Self-reported: Designed, split and run by the developer across perturbation, knockout, structure, splicing and regulation, with self-chosen comparators and metrics; per-item values appear only in the on-request white paper
- Replay of a known drug mechanism (Case study) Self-reported: Demonstrates a known kinase inhibitor's action in a leukaemia cell line; a case study, not prospective validation
Developers report: Developers report it is the only system covering all five task classes and matching or beating the strongest specialist baselines on most metrics of their own evaluation.
Independent evidence: No independent evidence found. The evaluation is vendor-built and vendor-run with no third-party reproduction, and neither weights nor white paper are public
Training data
Group in Figure 7: Not disclosed.
| Class | Value | Detail |
|---|---|---|
| a. Public databases | Not disclosed | This version's training data composition is undisclosed; the previous generation used public single-cell resources and is a different product source |
| b. Private or licensed data | Not disclosed | source |
| c. Own wet-lab data used for training | Not disclosed | source |
| d. Wet lab used only for validation | Not disclosed | Public material shows only a replay of a known drug mechanism, with no prospective wet-lab work mentioned source |
Wet-lab validation
None. The developers report no wet-lab validation.
Background
- Organization: The developer is an AI-native biology company headquartered in California with satellite labs in Europe and the Middle East, first presenting its digital-organism programme in 2024-12; founding year and headcount are not public.
- Funding: Press releases say only that it is backed by leading investors; round sizes and lead investors are not public.
- Products and partnerships: A first phase in 2024-12 covered six foundation models across DNA, RNA and single cells, and this virtual-cell product followed; researchers from several universities took part and no pharmaceutical partnerships are public.
- Related models: STATE, Lingshu-Cell, scGPT / Geneformer
Reading notes
- A vendor-built, vendor-run evaluation is not a blind test: tasks, splits and comparators are the vendor's and per-item values are not public.
- A count aggregated across structure, splicing, regulation and perturbation cannot be converted into usability on any one task class.
- Only two prototype cell types exist and no prospective wet-lab validation has been seen.
- The previous-generation single-cell model and this version are different products and their figures must not be mixed.
Caveats
- Under this round's relation rules it enters the zero-pairing list: the model card's claim names no benchmark and gives no figures.
- Weights and full materials are not public, so no claim can be checked externally.
- Two dates circulate for the launch; this record takes the one from same-day coverage.
Sources
- Official product page (official page)
- Press coverage (launch day) (news) · 2026-08-18
- Previous-generation model card (model hub)
- Previous-generation preprint (preprint)
Corrections
1 correction
| Field | Was | Now | Basis | Found |
|---|---|---|---|---|
| benchmarks_reported | Self-reported lead on this single-cell integration benchmark (self) | Changed to unconfirmed: the model card does not name the benchmark, gives no numbers, and refers to the previous-generation product | source | 2026-11-16 |
Part of the AI for Bio benchmarks survey · all 112 models · open in the explorer. Record as of 2026-11-16.